Does Rallies show Form 4 insider transactions for BJDX?

Yes. Rallies tracks BJDX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is BJDX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BJDX. It does not provide personalized investment advice.

BJDX (Bluejay Diagnostics, Inc. Common Stock) Stock Analysis - Insider Trades

Bluejay Diagnostics, Inc. Common Stock (BJDX) is a publicly traded Healthcare sector company. As of May 21, 2026, BJDX trades at $1.70 with a market cap of $1.78M and a P/E ratio of -0.11. BJDX moved +0.00% today. Year to date, BJDX is -32.95%; over the trailing twelve months it is -76.73%. Its 52-week range spans $1.62 to $49.80. Rallies surfaces BJDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading BJDX stock inside the company?

Recent BJDX insider activity includes Wurth Douglas Clark bought 12.50K, Dey Indranil bought 12.50K, CHASE DONALD R bought 12.50K, ZEIDMAN FRED S bought 12.50K, and Dey Svetlana bought 12.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

BJDX Key Metrics

Key financial metrics for BJDX
Metric	Value
Price	$1.70
Market Cap	$1.78M
P/E Ratio	-0.11
EPS	$-15.25
Dividend Yield	0.00%
52-Week High	$49.80
52-Week Low	$1.62
Volume	32
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-6.85M
Gross Margin	0.00%

Recent BJDX Insider Trades

Wurth Douglas Clark bought 12.50K (~$25.00K) on Mar 14, 2026.
Dey Indranil bought 12.50K (~$25.00K) on Mar 14, 2026.
CHASE DONALD R bought 12.50K (~$25.00K) on Mar 14, 2026.
ZEIDMAN FRED S bought 12.50K (~$25.00K) on Mar 14, 2026.
Dey Svetlana bought 12.50K (~$25.00K) on Mar 14, 2026.

Latest BJDX News

Bluejay Diagnostics Enrolls 680 of 750 Patients, Bolsters Symphony Manufacturing Readiness — May 7, 2026
Bluejay Diagnostics Reports $5.2M Cash, Advances SYMON II Sepsis Test Study — Mar 6, 2026
Bluejay Diagnostics Tops 545-Patient Enrollment and Secures Capacity for 10M Test Cartridges — Feb 17, 2026

BJDX Analyst Consensus

BJDX analyst coverage data. Average price target: $0.00.

Common questions about BJDX

Who is trading BJDX stock inside the company?: Recent BJDX insider activity includes Wurth Douglas Clark bought 12.50K, Dey Indranil bought 12.50K, CHASE DONALD R bought 12.50K, ZEIDMAN FRED S bought 12.50K, and Dey Svetlana bought 12.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for BJDX?: Yes. Rallies tracks BJDX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is BJDX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BJDX. It does not provide personalized investment advice.